Single channel, multiple drug delivery device and methods

US2018338904A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018338904-A1
Application numberUS-201815996349-A
CountryUS
Kind codeA1
Filing dateJun 1, 2018
Priority dateSep 27, 2012
Publication dateNov 29, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Devices and methods are provided for drug delivery. The device may include a housing configured for intralumenal deployment into a human or animal subject and a reservoir contained within the housing and having an actuation end and a release end. The release end may include at least one outlet. A first drug formulation and a second drug formulation may be disposed within the reservoir and adjacent to each other and immiscible, or separated from each other by a first barrier. The device may also include a plug within the reservoir at the actuation end, the plug being movable toward the release end to drive the first and second drug formulations out of the reservoir. The device may also include an actuation system operably connected to the actuation end of the reservoir and configured to drive the plug toward the release end and release the drug formulations from the reservoir.

First claim

Opening claim text (preview).

1 - 15 . (canceled) 16 . A device for drug delivery comprising: a housing configured for intraluminal deployment into a human or animal subject; a reservoir contained within the housing and having an actuation end and a release end, the release end comprising at least one outlet; a first drug formulation disposed within the reservoir; a second drug formulation disposed within the reservoir and separated from the first drug formulation by a first barrier; a plug at the actuation end within the reservoir, the plug being movable toward the release end to drive the first and second drug formulations out of the reservoir; an actuation system operably connected to the actuation end of the reservoir and configured to drive the plug toward the release end such that the first drug formulation is released from the reservoir before the second drug formulation is released from the reservoir; and a barrier retention chamber connected to the release end of the reservoir and configured to receive and retain the first barrier before the release of the second drug formulation. 17 . The device of claim 16 , wherein the first barrier comprises an inert gel. 18 . The device of claim 16 , wherein the first barrier comprises a solid barrier. 19 . The device of claim 16 , wherein the reservoir is defined by an inner surface of an elongated annular tube. 20 . The device of claim 16 , wherein the release end of the reservoir comprises a ring of outlets. 21 . The device of claim 16 , wherein the housing comprises a porous membrane sidewall in fluid communication with the at least one outlet of the release end of the reservoir, the porous membrane sidewall being configured to control diffusion of the first and second drug formulations released from the reservoir. 22 . The device of claim 21 , wherein the porous membrane sidewall comprises a polypropylene membrane. 23 . The device of claim 21 , wherein the porous sidewall membrane has a pore size from about 0.2 μm to about 25 μm. 24 . The device of claim 16 , wherein the barrier retention chamber comprises a hydrophobic vent 25 - 31 . (canceled)

Assignees

Inventors

Classifications

  • A61K9/0004Primary

    Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas · CPC title

  • Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time (artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50) · CPC title

  • Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018338904A1 cover?
Devices and methods are provided for drug delivery. The device may include a housing configured for intralumenal deployment into a human or animal subject and a reservoir contained within the housing and having an actuation end and a release end. The release end may include at least one outlet. A first drug formulation and a second drug formulation may be disposed within the reservoir and adjac…
Who is the assignee on this patent?
Inguran Llc
What technology area does this patent fall under?
Primary CPC classification A61K9/0004. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Nov 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).